Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
STAT+
Health
Biotech
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Fears about Trump rumble through the drug industry’s biggest conference

  • Rebecca Robbins

By Rebecca Robbins Jan. 11, 2017

Reprints
JP Morgan 2017
Alex Hogan/STAT

SAN FRANCISCO — President-elect Donald Trump sent biotech stocks plunging with his sharp remarks on Wednesday rapping the drug industry for “getting away with murder” on pricing and offshore production.

And that just added to the worries furrowing brows here this week at the annual J.P. Morgan Healthcare Conference is the drug industry’s biggest week of the year.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Rebecca Robbins

Rebecca Robbins

Health Tech Correspondent

Rebecca covers health technology. She is the co-author of the newsletter STAT Health Tech.

Tags

Top FDA official: Agency needs to start using accelerated…
Top FDA official: Agency needs to start using accelerated approval for gene therapies
The fungal crisis is here and desperately needs addressing
The fungal crisis is here and desperately needs addressing
‘Microdosing’ is touted by ’shroomers and Reddit users. Science…
‘Microdosing’ is touted by ’shroomers and Reddit users. Science is starting to test their claims —…
Senator calls for probe of conflict of interest on…
Senator calls for probe of conflict of interest on federal panel overseeing dietary guidelines
Arizona plans to dramatically increase hepatitis C testing and…
Arizona plans to dramatically increase hepatitis C testing and treatment in prisons
Top FDA official: Agency needs to start using accelerated…
Top FDA official: Agency needs to start using accelerated approval for gene therapies

Recommended Stories